| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 47.56% | 2.99% | 3.31% | 79/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 46.03% | -12.89% | -0.55% | 81/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 46.28% | -4.18% | -1.24% | 83/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 46.86% | -3.67% | 1.49% | 81/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 46.18% | 3% | -12.62% | 80/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 52.84% | 4.99% | 9.39% | 72/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 48.31% | 15.26% | -0.71% | 81/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 48.65% | 18.65% | 8.52% | 80/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 44.83% | 4.49% | -10.93% | 81/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 50.33% | -5.85% | 20.09% | 77/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 41.91% | -28.79% | 2.21% | 91/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 41% | -30.95% | -4.44% | 93/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 42.91% | -29.4% | -19.74% | 88/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 53.46% | -13.54% | -9.16% | 72/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 58.85% | -5.79% | -0.89% | 60/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 59.38% | -6.65% | -2.29% | 62/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 60.78% | 2% | -1.71% | 56/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 61.83% | -14.76% | -1.02% | 59/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 62.47% | 2% | -1.8% | 53/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 63.61% | -22.33% | -12.3% | 55/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 72.53% | 69.58% | -11.43% | 37/140 | 60.12% | 正海生物 | 90.78% | 行业排名> |
| 2020-06-30 | 81.9% | 2% | 91.48% | 14/140 | 60.36% | 正海生物 | 91.59% | 行业排名> |
| 2019-12-31 | 42.77% | 11.23% | 11.23% | 89/140 | 56.96% | 正海生物 | 92.23% | 行业排名> |
| 2018-12-31 | 38.45% | 0.21% | 0.21% | 85/140 | 56.22% | 正海生物 | 92.69% | 行业排名> |
| 2017-12-31 | 38.37% | 2% | 2% | 79/140 | 56.1% | 正海生物 | 92.61% | 行业排名> |

微信公众号
证券之星APP


